The Biopharmaceutical Cold Chain Transport ecosystem spans the full product lifecycle, linking upstream manufacturers of temperature‑sensitive biologics to downstream health‑care providers that administer the therapies. Upstream activities include formulation, fill‑finish, and primary packaging, which generate the cold‑chain requirements. Midstream participants design, build, and operate refrigerated transport assets, integrate monitoring technologies, and manage logistics networks that preserve the cold chain across road, air, and rail. Downstream actors receive, store, and dispense the products within hospitals, pharmacies, and specialty clinics. Value is created through coordinated preservation of product potency and captured via service contracts, performance‑based fees, and compliance incentives.